Methyldopate hydrochloride - Generic Drug Details
What are the generic sources for methyldopate hydrochloride and what is the scope of patent protection?
Methyldopate hydrochloride
is the generic ingredient in two branded drugs marketed by Merck, Abraxis Pharm, Am Regent, Baxter Hlthcare, Hospira, Marsam Pharms Llc, Smith And Nephew, and Teva Parenteral, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.Summary for methyldopate hydrochloride
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 8 |
| NDAs: | 11 |
| Drug Master File Entries: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 532 |
| DailyMed Link: | methyldopate hydrochloride at DailyMed |
US Patents and Regulatory Information for methyldopate hydrochloride
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Parenteral | METHYLDOPATE HYDROCHLORIDE | methyldopate hydrochloride | INJECTABLE;INJECTION | 072974-001 | Nov 22, 1991 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Smith And Nephew | METHYLDOPATE HYDROCHLORIDE | methyldopate hydrochloride | INJECTABLE;INJECTION | 070841-001 | Jan 2, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Marsam Pharms Llc | METHYLDOPATE HYDROCHLORIDE | methyldopate hydrochloride | INJECTABLE;INJECTION | 071812-001 | Dec 22, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Merck | ALDOMET | methyldopate hydrochloride | INJECTABLE;INJECTION | 013401-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
